This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
Utility Stocks' Earnings to Watch on Feb 22: D, PCG & More
by Aparajita Dutta
Total fourth-quarter earnings of Utility stocks are expected to improve 15.3% year over year on a decline of 4.7% in revenues. Let's see how D, PCG, EIX, AEE, ETR & CWEN perform this time around.
AEENegative Net Change ETRNegative Net Change EIXNegative Net Change PCGNegative Net Change DNegative Net Change CWENPositive Net Change
earnings utilities
Energy Stocks' Q4 Earnings Roster for Feb 21: WES, APA & MRO
by Urbashi Dutta
Lower commodity prices are likely to have affected the upstream businesses. Let us see how Western Midstream (WES), APA Corp (APA) and Marathon Oil (MRO) are placed ahead of Q4 earnings.
MROPositive Net Change APANegative Net Change WESNegative Net Change
energy oil-energy
Drug, Biotech Stock Q4 Earnings Due on Feb 15: ALNY, BPMC & More
by Zacks Equity Research
Let's look at five biotech/drug companies, ALNY, BPMC, AGIO, CORT and RARE, slated to release quarterly results on Feb 15.
ALNYPositive Net Change CORTNegative Net Change AGIOPositive Net Change RAREPositive Net Change
biotechnology biotechs earnings medical pharmaceuticals
Medical Products Stocks' Earnings Due on Feb 15: WST, ITGR & More
by Debanjana Dey
Medical Products companies' quarterly results are likely to reflect strength in customer demand. Let's see how ITGR, WST, AMN and PACB are placed ahead of their earnings releases.
AMNPositive Net Change WSTNo Net Change PACBPositive Net Change ITGRPositive Net Change
earnings medical medical-devices
Drug, Biotech Stocks' Q4 Earnings Due on Feb 13: BIIB, ZTS & INCY
by Zacks Equity Research
Let's take a look at three biotech/drug companies, BIIB, ZTS, and INCY, slated to release quarterly results on Feb 13.
BIIBPositive Net Change INCYPositive Net Change ZTSPositive Net Change
biotechs medical
Medical Device Stocks' Earnings Due on Feb 13: ECL, DVA & QDEL
by Indrajit Bandyopadhyay
Medical Device companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how ECL, DVA and QDEL fare this time.
ECLPositive Net Change DVAPositive Net Change QDELNegative Net Change
medical medical-devices
Aerospace & Defense Stocks to Post Earnings on Feb 13: LDOS & KTOS
by Aparajita Dutta
Earnings from the Aerospace sector, which houses the aerospace & defense stocks, are expected to have improved 10.1% from the prior-year quarter's reported figure. Let's see how LDOS & KTOS report.
KTOSNegative Net Change LDOSNegative Net Change
aerospace earnings
Utility Stocks Reporting Q4 Earnings on Feb 8: FE, DUK & DTE
by Tanvi Sarawagi
Let's focus on utilities like FE, DUK and DTE, which are scheduled to release fourth-quarter 2023 earnings on Feb 8.
FENegative Net Change DUKNegative Net Change DTENegative Net Change
utilities
Medical Products Stocks' Earnings Due on Feb 7: STE, PAHC & NVST
by Urmimala Biswas
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how STE, PAHC and NVST fare this time.
STENegative Net Change PAHCPositive Net Change NVSTNegative Net Change
earnings medical
Insurance Stocks to Post Q4 Earnings on Feb 7: RDN, EG & More
by Sushmita Sarker
Favorable reserve development, prudent underwriting, exposure growth across business lines and improved pricing, partly offset by catastrophe losses, are likely to have influenced the fourth-quarter performances of RDN, EG, FAF, SLF and ALL.
ALLNegative Net Change FAFNegative Net Change RDNNegative Net Change SLFPositive Net Change EGNegative Net Change
insurance
Insurance Stocks' Q4 Earnings Due on Feb 6: WTW, PRU & More
by Tanuka De
Insurers like WTW, PRU, AIZ, CINF and AFG are due to report fourth-quarter 2023 earnings tomorrow. Let's see what's in store for them.
PRUNegative Net Change CINFNegative Net Change AIZNegative Net Change AFGNegative Net Change WTWPositive Net Change
earnings insurance
Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More
by Zacks Equity Research
Let's take a look at four biotech, drug companies, AMGN, LLY, GILD and EXEL, slated to release quarterly results on Feb 6.
LLYPositive Net Change AMGNPositive Net Change GILDNegative Net Change EXELNegative Net Change
biotechs medical
Medical Device Stocks' Earnings on Feb 1: RVTY, CAH & More
by Debanjana Dey
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how CAH, RVTY, CNMD, SRDX and BDX are placed ahead of their earnings releases.
BDXPositive Net Change CNMDPositive Net Change CAHNegative Net Change SRDXNegative Net Change RVTYPositive Net Change
earnings medical medical-devices
Insurance Stocks' Q4 Earnings Due on Jan 31: AFL, MET & More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to drive fourth-quarter results of insurers like AFL, MET, AXS, SIGI and MTG.
MTGNegative Net Change METNegative Net Change AFLPositive Net Change AXSNegative Net Change SIGINegative Net Change
earnings insurance
Medical Products Q4 Earnings Due on Jan 31: BSX, TMO & ALGN
by Urmimala Biswas
Medical Products companies' fourth-quarter results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO and ALGN fare this time.
BSXNegative Net Change ALGNNegative Net Change TMOPositive Net Change
earnings medical
Drug, Biotech Stocks' Q4 Earnings Due on Jan 31: NVO, NVS & GSK
by Ahan Chakraborty
Let's look at three biotech/drug companies, NVO, NVS and GSK, slated to release quarterly results on Jan 31.
GSKPositive Net Change NVSPositive Net Change JNJPositive Net Change NVOPositive Net Change
biotechnology biotechs medical pharmaceuticals
Medical Product Stocks' Q4 Earnings Due on Jan 30: SYK & More
by Indrajit Bandyopadhyay
Fourth-quarter results of Medical Product companies are likely to reflect a year-over-year improvement in revenues. Let's see how SYK, COR and ARAY fare this time around.
ARAYNegative Net Change SYKPositive Net Change CORNegative Net Change
medical medical-devices
3 Asset Management Stocks Set to Pull Off Earnings Beat in Q4
by Swayta Shah
Driven by solid market performance and moderate improvement in the operating backdrop, asset managers - SEI Investments (SEIC), T. Rowe Price (TROW) and Principal Financial (PFG) - are set to surpass estimates in Q4.
BLKNegative Net Change TROWNegative Net Change PFGNegative Net Change SEICNegative Net Change
earnings finance
Airline Stocks' Q4 Earnings Roster for Jan 25: AAL, ALK, LUV
by Zacks Equity Research
Investors interested in the Airline industry can watch out for fourth-quarter 2023 earnings reports of AAL, ALK and LUV, which are slated to release on Jan 25.
LUVPositive Net Change AALPositive Net Change ALKPositive Net Change
earnings transportation
Biotech/Drug Stocks Q3 Earnings Due Nov 7: GILD, PRGO, VTRS & More
by Zacks Equity Research
Let us take a look at what's in store for biotech/drug stocks GILD, PRGO, VTRS, SAGE and IOVA, which are scheduled to report on Nov 7.
BMYPositive Net Change GILDNegative Net Change PRGONegative Net Change IOVAPositive Net Change VTRSNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
Energy Stocks' Q3 Earnings Roster for Nov 7: CIVI, DVN, WTI
by Nilanjan Banerjee
Favorable commodity prices likely to have aided the upstream business. Let's see how Civitas Resources (CIVI), Devon Energy (DVN) and W&T Offshore (WTI) are placed ahead of Q3 earnings.
DVNNegative Net Change WTINegative Net Change CIVINegative Net Change
oil-energy
Service Stocks' Nov 2 Earnings Roster: BR, APTV & PLTR
by Zacks Equity Research
Investors interested in the Business Services sector can watch out for earnings reports of BR, APTV and PLTR, to be released on Nov 2.
BRPositive Net Change APTVNegative Net Change PLTRNegative Net Change
business-services earnings
Medical Product Stocks' Q3 Earnings Due on Nov 1: SYK & More
by Indrajit Bandyopadhyay
Third-quarter results of Medical Product companies are likely to reflect a year-over-year decline. Let's see how SYK, COR, BAX, FMS and XRAY fare this time around.
BAXNegative Net Change SYKPositive Net Change XRAYNegative Net Change FMSPositive Net Change CORNegative Net Change
medical medical-devices
Utility Stocks Reporting Q3 Earnings on Nov 2: ED, DUK & More
by Tanvi Sarawagi
Let's focus on utilities like ED, DUK, EXC, PNW, LNT and NRG, which are scheduled to release third-quarter 2023 earnings on Nov 2.
EXCNegative Net Change NRGNegative Net Change DUKNegative Net Change EDNegative Net Change PNWNegative Net Change LNTNegative Net Change
utilities
MedTech Stocks' Q3 Earnings Due on Nov 1: IDXX, EXAS & More
by Urmimala Biswas
MedTech companies' third-quarter results are likely to reflect a year-over-year decline. Let's see how IDXX, EXAS, TNDM and NVST fare this time.
IDXXNegative Net Change EXASPositive Net Change TNDMPositive Net Change NVSTNegative Net Change
earnings medical